In Vitro and In Vivo Antimalarial Activity Assays of Seeds from Balanites aegyptiaca: Compounds of the Extract Show Growth Inhibition and Activity against Plasmodial Aminopeptidase

• Main Authors: Peter Kusch, Susanne Deininger, Sabine Specht, Rudeka Maniako, Stefanie Haubrich, Tanja Pommerening, Paul Kong Thoo Lin, Achim Hoerauf, Annette Kaiser
• Format: Article
• Language: English
• Published: Hindawi Limited 2011-01-01
• Series: Journal of Parasitology Research
• Online Access: http://dx.doi.org/10.1155/2011/368692
• ISSN: 2090-0023; 2090-0031

Balanites aegyptiaca (Balanitaceae) is a widely grown desert plant with multiuse potential. In the present paper, a crude extract from B. aegyptiaca seeds equivalent to a ratio of 1 : 2000 seeds to the extract was screened for antiplasmodial activity. The determined IC50 value for the chloroquine-susceptible Plasmodium falciparum NF54 strain was 68.26 𝜇g/𝜇L±3.5. Analysis of the extract by gas chromatography-mass spectrometry detected 6-phenyl-2(H)-1,2,4-triazin-5-one oxime, an inhibitor of the parasitic M18 Aspartyl Aminopeptidase as one of the compounds which is responsible for the in vitro antiplasmodial activity. The crude plant extract had a 𝐾𝑖 of 2.35 𝜇g/𝜇L and showed a dose-dependent response. After depletion of the compound, a significantly lower inhibition was determined with a 𝐾𝑖 of 4.8 𝜇g/𝜇L. Moreover, two phenolic compounds, that is, 2,6-di-tert-butyl-phenol and 2,4-di-tert-butyl-phenol, with determined IC50 values of 50.29 𝜇M±3 and 47.82 𝜇M±2.5, respectively, were detected. These compounds may contribute to the in vitro antimalarial activity due to their antioxidative properties. In an in vivo experiment, treatment of BALB/c mice with the aqueous Balanite extract did not lead to eradication of the parasites, although a reduced parasitemia at day 12 p.i. was observed.